Marinus Pharmaceuticals, Inc.

CIK 1267813 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Marinus Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
May 15, 2025SCHEDULE 13G/A0000935836-25-000348
Mar 6, 2025SCHEDULE 13G/A0000895421-25-000305
Feb 21, 202515-12G0001104659-25-015905
Feb 14, 2025SCHEDULE 13G/A0001214659-25-002806
Feb 14, 2025SCHEDULE 13G/A0000950170-25-021289
Feb 13, 2025EFFECT9999999995-25-000435
Feb 13, 2025EFFECT9999999995-25-000434
Feb 13, 2025EFFECT9999999995-25-000436
Feb 12, 2025SCHEDULE 13G/A0000919574-25-001031
Feb 11, 202540001104659-25-011243
Feb 11, 20258-K0001104659-25-011211
Feb 11, 2025POS AM0001104659-25-011220
Feb 11, 2025S-8 POS0001104659-25-011230
Feb 11, 202540001104659-25-011244
Feb 11, 202525-NSE0001354457-25-000089
Feb 11, 202540001104659-25-011247
Feb 11, 2025S-8 POS0001104659-25-011227
Feb 11, 2025S-8 POS0001104659-25-011226
Feb 11, 2025S-8 POS0001104659-25-011228
Feb 11, 2025SCHEDULE 13G/A0000919574-25-000964
Feb 11, 2025S-8 POS0001104659-25-011233
Feb 11, 202540001104659-25-011248
Feb 11, 2025SCHEDULE 13G0000919574-25-000967
Feb 11, 2025SCHEDULE 13G/A0000038777-25-000025
Feb 11, 202540001104659-25-011246